Articles, App Notes, Case Studies, & White Papers
-
Sample Sizes For Performance Testing Of Combination Products, Packaging
5/16/2025
When developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.
-
24/7 Cell & Gene Control Tower Provides Agile Solution For Critical Shipments
3/1/2023
Get an overview of a successful re-route of six critical shipments to the UK and Spain from Amsterdam used to deliver CAR-T drug products to treat non-Hodgkin’s lymphoma cancer patients.
-
Overcoming The Challenges Of Fragmented Supply Chains
1/27/2025
As trials grow more complex, managing clinical supplies is increasingly challenging. In this webinar, experts discussed GxP inventory management and integrated solutions to overcome these hurdles.
-
Five Key Trends In CMC
3/18/2025
CMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.
-
The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets
10/4/2024
Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.
-
Improving Site Efficiency With Automated Drug Resupply And Forecasting
8/22/2025
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
Building Robust Clinical Supply Chains To Support Global Trials
Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.
-
Winning The Race To FPI With Early Randomization And Trial Supply Management
9/8/2022
Learn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
Is Your Clinical Supply Strategy Ready For EU CTR?
3/3/2022
One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
-
Key Considerations For Emerging Companies When Selecting Packaging Components
Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.